ATOS - Atossa Genetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $4.27. This is a potential upside of $3.53 (477.03%) from yesterday's end of day stock price of $0.74.

Atossa Genetics's activity chart (see below) currently has 7 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 87.5% with an average time for these price targets to be met of 116.5 days.

Most recent stock forecast was given by EDWARD WOO from ASCENDIANT on 03-Mar-2022. First documented stock forecast 26-Jan-2018.

Best performing analysts who are covering ATOS - Atossa Genetics:

Edward Woo Jason Mccarthy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

3 years 5 months 18 days ago
(03-Mar-2022)

2/2 (100%)

$4.13 (106.72%)

51

Buy

$7

$5.98 (586.27%)

$8

4 years 2 months 10 days ago
(10-Jun-2021)

3/4 (75%)

$2.93 (71.99%)

182

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATOS (Atossa Genetics) average time for price targets to be met?

On average it took 116.5 days on average for the stock forecasts to be realized with a an average price target met ratio 87.5

Which analyst has the current highest performing score on ATOS (Atossa Genetics) with a proven track record?

EDWARD WOO

Which analyst has the current lower performing score on ATOS (Atossa Genetics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ATOS (Atossa Genetics)?

Edward Woo works at ASCENDIANT and has 1 price targets and 2 ratings on ATOS

Which analyst is the currently most bullish on ATOS (Atossa Genetics)?

Jason Mccarthy with highest potential upside - $5.98

Which analyst is the currently most reserved on ATOS (Atossa Genetics)?

Edward Woo with lowest potential downside - -$0

Atossa Genetics in the News

Advanced Authentication Market Outlook Report 2025-2029: Advanced Authentication Market to Surge by USD 75.57 Billion from 2024-2029, Driven by Online Transactions Boom

Dublin, Aug. 01, 2025 (GLOBE NEWSWIRE) — The “Advanced Authentication Market 2025-2029” has been added to ResearchAndMarkets.com’s offering. The advanced authentication market is projected to expand by USD 75.57 billion from 2024 to 2029, with a swift CAGR of 21.6% during the forecast period. This comprehensive market report offers a holistic assessment, encompassing market size...

Atos posts H1 drop in orders and revenue on weak demand, tough market backdrop

Investing.com — French IT company Atos reported a drop in both revenue and orders for the first half (H1) of the year, citing weak commercial activity in France and a difficult market backdrop. Order intake reached €3.3 billion over the six-month period, down from €3.6 billion a year ago. Despite the decline, the book-to-bill ratio...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?